DexCom (NASDAQ: DXCM) is not a stock that investors should be rushing to sell. It has a few different opportunities to ...
Biosensors that measure glucose are now available without a prescription. Wearing one burst my wellness bubble in ways I wasn ...
With the company's market cap of $28 billion today, it's important to recognize that DexCom (NASDAQ: DXCM) is already one of ...
The agency approved the first over-the-counter continuous glucose monitor, known as Stelo, for adults with diabetes who do ...
St. Louis-based diabetes treatment startup Aegis Digital Health is nearing $1 million in its latest funding round and seeing ...
The FDA cleared Eversense 365 as the first 1-year integrated continuous glucose monitoring (CGM) system for adults with type ...
Zacks.com on MSN1d
Senseonics Stock Down Despite New FDA Approval for Eversense 365Senseonics Holdings, Inc. SENS, along with Ascensia Diabetes Care, announced the receipt of the FDA’s clearance for the ...
In other legal news, the Texas Attorney General has reached a settlement with a Dallas health AI company that the government ...
GERMANTOWN, Md., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable ...
Remote patient monitoring has exploded since the pandemic. In just four years from the beginning of 2019 through 2022, ...
Synex Medical just raised $21.8 million to build a portable MRI capable of testing glucose and other important molecules ...
Dexcom (Nasdaq:DXCM) today announced a collaboration to establish National Glucose Awareness Week from Sept. 23-29, 2024.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback